According to Foghorn Therapeutics's latest financial reports the company's current revenue (TTM ) is €20.85 Million. a decrease over the revenue in the year 2023 that were of €30.89 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.